639 related articles for article (PubMed ID: 7687975)
1. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
Takeda Y
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels.
Takeda Y; Tohse N; Nakaya H; Kanno M
Br J Pharmacol; 1995 Oct; 116(3):2134-40. PubMed ID: 8640356
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Bay K8644 and nifedipine on L-type Ca2+ channels in hypothalamic neurons of rats].
Fu QJ; Zou F
Sheng Li Xue Bao; 2001 Oct; 53(5):339-43. PubMed ID: 11833415
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Barrús MT; Reviriego J; Marín J
J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
[TBL] [Abstract][Full Text] [Related]
5. [Calcium channels in bullfrog saccular hair cells].
Su Z; Jiang S; Gu R
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(2):70-3. PubMed ID: 7544598
[TBL] [Abstract][Full Text] [Related]
6. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
Hattori Y; Nakaya H; Tohse N; Kanno M
J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
[TBL] [Abstract][Full Text] [Related]
7. Effects of Bay K 8644 on L-type calcium current from newborn rat cardiomyocytes in primary culture.
Gomez JP; Fares N; Potreau D
J Mol Cell Cardiol; 1996 Oct; 28(10):2217-29. PubMed ID: 8930816
[TBL] [Abstract][Full Text] [Related]
8. Kupffer cells contain voltage-dependent calcium channels.
Hijioka T; Rosenberg RL; Lemasters JJ; Thurman RG
Mol Pharmacol; 1992 Mar; 41(3):435-40. PubMed ID: 1372081
[TBL] [Abstract][Full Text] [Related]
9. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.
Liu H; Sperelakis N
Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814
[TBL] [Abstract][Full Text] [Related]
11. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
Nakaya H; Hattori Y; Tohse N; Kanno M
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein.
Liu H; Xiong Z; Sperelakis N
J Mol Cell Cardiol; 1997 May; 29(5):1411-21. PubMed ID: 9201626
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine and tetrodotoxin delay the onset of methylmercury-induced increase in [Ca2+]i in NG108-15 cells.
Hare MF; Atchison WD
Toxicol Appl Pharmacol; 1995 Dec; 135(2):299-307. PubMed ID: 8545840
[TBL] [Abstract][Full Text] [Related]
14. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644.
Usowicz MM; Gigg M; Jones LM; Cheung CW; Hartley SA
J Pharmacol Exp Ther; 1995 Nov; 275(2):638-45. PubMed ID: 7473149
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes.
Kanaya N; Matsumoto M; Kawana S; Tsuchida H; Kimura H; Miyamoto A; Ohshika H; Namiki A
Can J Anaesth; 1998 Jun; 45(6):584-91. PubMed ID: 9669017
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
Rampe D; Anderson B; Rapien-Pryor V; Li T; Dage RC
J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384
[TBL] [Abstract][Full Text] [Related]
17. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
[TBL] [Abstract][Full Text] [Related]
18. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
[TBL] [Abstract][Full Text] [Related]
19. Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers.
Hering S; Hughes AD; Timin EN; Bolton TB
J Gen Physiol; 1993 Mar; 101(3):393-410. PubMed ID: 7682596
[TBL] [Abstract][Full Text] [Related]
20. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
